Search hospitals > Quebec > MONTREAL
Jewish General Hospital
Claim this profileMONTREAL, Quebec H3T 1E2
Global Leader in Breast Cancer
Global Leader in Prostate Cancer
Conducts research for Parotid Gland Cancer
Conducts research for Prostatic Neoplasm
Conducts research for Lymphoma
527 reported clinical trials
31 medical researchers
Summary
Jewish General Hospital is a medical facility located in MONTREAL, Quebec. This center is recognized for care of Breast Cancer, Prostate Cancer, Parotid Gland Cancer, Prostatic Neoplasm, Lymphoma and other specialties. Jewish General Hospital is involved with conducting 527 clinical trials across 596 conditions. There are 31 research doctors associated with this hospital, such as Cristiano Ferrario, MD, Dr. Tamim Niazi, MDCM, Petr Kavan, Dr, and Wilson Miller.Area of expertise
1Breast Cancer
Global LeaderStage IV
HER2 negative
Stage III
2Prostate Cancer
Global LeaderStage IV
metastatic
testosterone
Top PIs
Cristiano Ferrario, MDJewish General Hospital8 years of reported clinical research
Studies Breast Cancer
Studies Prostatic Neoplasm
13 reported clinical trials
38 drugs studied
Dr. Tamim Niazi, MDCMJewish General Hospital, McGill University5 years of reported clinical research
Expert in Prostate Cancer
Studies Prostatic Neoplasm
11 reported clinical trials
30 drugs studied
Petr Kavan, DrJewish General Hospital3 years of reported clinical research
Studies Pancreatic Cancer
Studies Non-Hodgkin's Lymphoma
10 reported clinical trials
39 drugs studied
Wilson MillerJewish General Hospital3 years of reported clinical research
Studies Melanoma
Studies Cystic Tumor
9 reported clinical trials
14 drugs studied
Clinical Trials running at Jewish General Hospital
Breast Cancer
Multiple Myeloma
Prostate Cancer
Chronic Lymphocytic Leukemia
Lymphoma
Non-Small Cell Lung Cancer
Lung Cancer
Colorectal Cancer
Deep Vein Thrombosis
Plasma Cell Neoplasm
Sacituzumab Govitecan
for Triple-Negative Breast Cancer
This trial is testing a drug called sacituzumab govitecan-hziy, which targets and kills cancer cells. It focuses on patients with advanced triple-negative breast cancer who have limited treatment options. The drug works by attaching to cancer cells and releasing a substance that kills them. Sacituzumab govitecan-hziy is an FDA-approved treatment for metastatic triple-negative breast cancer, especially for patients who have already tried other treatments.
Recruiting4 awards Phase 3
sac-TMT + Pembrolizumab
for Breast Cancer
This is a randomized, open-label study comparing the efficacy and safety of adjuvant sacituzumab tirumotecan (MK-2870) in combination with pembrolizumab compared to treatment of physician's choice (TPC) in participants with triple-negative breast cancer (TNBC) who received neoadjuvant therapy and did not achieve a pathological complete response (pCR) at surgery. The primary objective is to compare sacituzumab tirumotecan plus pembrolizumab to TPC (pembrolizumab or pembrolizumab plus capecitabine) with respect to invasive disease-free survival (iDFS) per investigator assessment. It is hypothesized that sacituzumab tirumotecan plus pembrolizumab is superior to TPC with respect to iDFS per investigator assessment.
Recruiting2 awards Phase 35 criteria
Sacituzumab Tirumotecan + Pembrolizumab
for Breast Cancer
The purpose of this study is to compare sacituzumab tirumotecan as a single agent, and in combination with pembrolizumab, versus Treatment of Physician's Choice (TPC) in participants with hormone receptor positive/human epidermal growth factor receptor-2 negative (HR+/HER2-) unresectable locally advanced, or metastatic, breast cancer. The primary hypotheses are that sacituzumab tirumotecan as a single agent and sacituzumab tirumotecan plus pembrolizumab are superior to TPC with respect to progression-free survival (PFS) per Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST 1.1) by blinded independent central review (BICR) in all participants.
Recruiting2 awards Phase 33 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Jewish General Hospital?
Where is Jewish General Hospital located?
Who should I call to ask about financial aid or insurance network?
What insurance does Jewish General Hospital accept?
What awards or recognition has Jewish General Hospital received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.